Y. He et al. / Journal of Fluorine Chemistry 156 (2013) 9–14
13
4.2.11. 2-Fluoro-2,3-dihydro-1H-inden-1-one (2k) [14]
1H NMR (400 MHz, CDCl3)
: 3.16–3.26 (m, 1H), 3.59–3.65 (m,
1H), 5.18–5.33 (m, 1H), 7.42–7.46 (m, 2H), 7.64–7.68 (m, 1H),
7.77–7.79 (m, 1H). 13C NMR (100 MHz, CDCl3)
: 33.4 (d, JC-
F = 29.0 Hz). 19F NMR (376 MHz, CDCl3)
d
: ꢁ104.33, ꢁ118.20 (d,
d
JH-F = 36.0 Hz). MS: m/z 279 [MH]+. HRMS calcd for C15H10ClF2O:
279.0388 [M+H], found: 279.0371.
d
F = 21.0 Hz), 90.4 (d, JC-F = 189.0 Hz), 124.7, 126.8, 128.4, 133.9,
136.3, 149.6 (d, JC-F = 5.0 Hz), 199.9 (d, JC-F = 16.0 Hz). MS: m/z 151
[MH]+.
4.3.5. (Z)-1-(3-chlorophenyl)-2-fluoro-3-p-tolylprop-2-en-1-one
(6e)
1H NMR (400 MHz, CDCl3)
d: 2.40 (s, 3H), 6.87 (d, JH-F = 36.0 Hz,
1H), 7.24 (d, J = 8.0 Hz, 2H), 7.43 (t, J = 8.0 Hz, 1H), 7.56–7.62 (m,
3H), 7.77 (d, J = 8.0 Hz, 1H), 7.86 (s, 1H). 13C NMR (100 MHz, CDCl3)
4.3. Typical procedure for the preparation of (Z)-2-fluoro-1,3-di-p-
tolylprop-2-en-1-one (6a)
d: 21.6, 120.7 (d, JC-F = 6.0 Hz), 127.4 (d, JC-F = 4.0 Hz), 128.4 (d, JC-
F = 4.0 Hz), 129.3 (d, JC-F = 4.0 Hz), 129.7 (d, JC-F = 4.0 Hz), 130.76,
130.84, 132.7, 134.7, 137.9, 140.9, 153.8 (d, JC-F = 269.0 Hz), 186.4
To a flask containing an aqueous solution of sodium hydroxide
(0.7 mL, 10%) and EtOH (0.5 mL) were added 2-fluoro-1-p-
tolylethanone (2e, 1 mmol) and 4-methylbenzaldehyde (5a,
1 mmol). The mixture was stirred at room temperature. Upon
completion as monitored by TLC, the reaction was quenched with
aqueous NH4Cl. Then, the mixture was filtered on diatomite and
the filtrate was extracted with ethyl acetate (5 mL 3ꢂ). The
combined organic phases were dried, filtered and concentrated
under vacuum. The residue was purified by column chromatogra-
phy on silica gel eluting with ethyl acetate/hexanes (2%) to give (Z)-
2-fluoro-1,3-di-p-tolylprop-2-en-1-one (6a). 6b–6k were obtained
in a similar manner.
(d, JC-F = 29.0 Hz). 19F NMR (376 MHz, CDCl3)
d
: ꢁ121.10 (d, JH-
F = 36.0 Hz). MS: m/z 275 [MH]+. HRMS calcd for C16H13ClFO:
275.0639 [M+H], found: 275.0636.
4.3.6. (Z)-1-(3-chlorophenyl)-3-(4-chlorophenyl)-2-fluoroprop-2-
en-1-one (6f)
1H NMR (400 MHz, CDCl3)
d
: 6.85 (d, JH-F = 36.0 Hz, 1H), 7.39–
7.46 (m, 3H), 7.57–7.65 (m, 3H), 7.78 (d, J = 7.2 Hz, 1H), 7.87 (s, 1H).
13C NMR (100 MHz, CDCl3)
: 118.8 (d, JC-F = 6.0 Hz), 127.4 (d, JC-
d
F = 5.0 Hz), 129.3, 129.4 (d, JC-F = 5.0 Hz), 129.6 (d, JC-F = 4.0 Hz),
129.8, 131.9 (d, JC-F = 8.0 Hz), 133.0, 134.8, 136.3, 137.5, 154.4 (d,
JC-F = 272.0 Hz), 186.0 (d, JC-F = 29.0 Hz). 19F NMR (376 MHz, CDCl3)
4.3.1. (Z)-2-fluoro-1,3-di-p-tolylprop-2-en-1-one (6a)
d
C
: ꢁ119.07 (d, JH-F = 36.0 Hz). MS: m/z 295 [MH]+. HRMS calcd for
1H NMR (400 MHz, CDCl3)
d
: 2.38 (s, 3H), 2.43 (s, 3H), 6.85 (d, JH-
15H10Cl2FO: 295.0092 [M+H], found: 295.0074.
F = 36.4 Hz, 1H), 7.22 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 7.6 Hz, 2H), 7.60
(d, J = 8.0 Hz, 2H), 7.82 (d, J = 8.4 Hz, 2H). 13C NMR (100 MHz,
4.3.7. (Z)-3-(3-chlorophenyl)-2-fluoro-1-phenylprop-2-en-1-one
CDCl3)
d
: 21.5, 21.6, 119.8, 128.7 (d, JC-F = 4.0 Hz), 129.1, 129.5 (d,
(6g)
JC-F = 5.0 Hz), 129.6, 130.6 (d, JC-F = 9.0 Hz), 133.7, 140.3, 143.7,
154.4 (d, JC-F = 270.0 Hz), 187.4 (d, JC-F = 28.0 Hz). 19F NMR
1H NMR (400 MHz, CDCl3)
d
: 6.80 (d, JH-F = 35.2 Hz, 1H), 7.35 (t,
J = 3.2 Hz, 2H), 7.48–7.62 (m, 4H), 7.70 (s, 1H), 7.89 (d, J = 8.4 Hz,
2H). 13C NMR (100 MHz, CDCl3)
: 118.3, 128.6 (d, JC-F = 6.4 Hz),
128.7, 129.4 (d, JC-F = 4.4 Hz), 129.9 (d, JC-F = 2.7 Hz), 130.2 (d, JC-
F = 10.8 Hz), 130.3, 133.0 (d, JC-F = 3.7 Hz), 133.2, 134.8, 135.9,
155.0 (d, JC-F = 273.4 Hz), 187.5 (d, JC-F = 28.9 Hz). 19F NMR
(376 MHz, CDCl3)
d
: ꢁ119.98 (d, JH-F = 36.4 Hz). MS: m/z 255
d
[MH]+. HRMS calcd for C17H16FO: 255.1185 [M+H], found:
255.1166.
4.3.2. (Z)-3-(4-chlorophenyl)-2-fluoro-1-p-tolylprop-2-en-1-one
(376 MHz, CDCl3)
d
: ꢁ116.98 (d, JH-F = 35.2 Hz). MS: m/z 261
(6b)
[MH]+. HRMS calcd for C15H11ClFO: 261.0482 [M+H], found:
261.0483.
1H NMR (400 MHz, CDCl3)
d
: 2.43 (s, 3H), 6.80 (d, JH-F = 36.0 Hz,
1H), 7.29 (d, J = 7.2 Hz, 2H), 7.37 (d, J = 7.2 Hz, 2H), 7.62 (d, J = 7.6 Hz,
2H), 7.81 (d, J = 8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3)
: 21.7, 118.0
d
4.3.8. (Z)-2-fluoro-3-(4-fluorophenyl)-1-phenylprop-2-en-1-one
(d, JC-F = 6.0 Hz), 129.2 (d, JC-F = 7.0 Hz), 129.6 (d, JC-F = 4.0 Hz), 130.0
(d, JC-F = 4.0 Hz), 131.6, 131.8, 133.3, 135.8 (d, JC-F = 4.0 Hz), 144.1,
154.9 (d, JC-F = 274.0 Hz), 187.1(d, JC-F = 28.0 Hz). 19F NMR (376 MHz,
(6h)
1H NMR (400 MHz, CDCl3)
d
: 6.84 (d, JH-F = 36.0 Hz, 1H), 7.11 (t,
J = 8.4 Hz, 2H), 7.50 (t, J = 7.6 Hz, 2H), 7.58–7.62 (m, 1H), 7.68–7.71
(m, 2H), 7.88 (d, J = 7.2 Hz, 2H). 13C NMR (100 MHz, CDCl3)
: 116.1
CDCl3)
d
: ꢁ117.89 (d, JH-F = 36.0 Hz). MS: m/z 275 [MH]+. HRMS calcd
d
for C16H13ClFO: 275.0639 [M+H], found: 275.0635.
(d, JC-F = 21.9 Hz), 119.0, 127.6 (t, JC-F = 3.6 Hz), 128.5, 129.4 (d, JC-
F = 3.4 Hz), 132.6 (d, JC-F = 9.0 Hz), 132.9 (d, JC-F = 22.6 Hz), 136.1,
154.2 (d, JC-F = 267.9 Hz), 163.4 (dd, J1 C-F = 250.5 Hz, J2C-F = 4.0 Hz),
4.3.3. (Z)-2-fluoro-1-(4-fluorophenyl)-3-p-tolylprop-2-en-1-one
(6c)
187.8 (d, JC-F = 29.8 Hz). 19F NMR (376 MHz, CDCl3)
d
: ꢁ108.91,
1H NMR (400 MHz, CDCl3)
d
: 2.39 (s, 3H), 6.87 (d, JH-F = 36.0 Hz,
1H), 7.14–7.18 (m, 2H), 7.23 (d, J = 8.0 Hz, 2H), 7.60 (d, J = 8.0 Hz,
2H), 7.94–7.97 (m, 2H). 13C NMR (100 MHz, CDCl3)
: 21.5, 115.7
ꢁ120.47 (d, JH-F = 36.0 Hz). MS: m/z 245 [MH]+. HRMS calcd for
C15H11F2O: 245.0778 [M+H], found: 245.0782.
d
(d, JC-F = 22.0 Hz), 119.9 (d, JC-F = 6.0 Hz), 128.5 (d, JC-F = 4.0 Hz),
129.6, 130.7 (d, JC-F = 9.0 Hz), 132.1 (dd, J1C-F = 9.0 Hz, J2C-
F = 5.0 Hz), 132.5, 140.6, 154.2 (d, JC-F = 270.0 Hz), 165.6 (d, JC-
4.3.9. (Z)-3-(4-bromophenyl)-2-fluoro-1-phenylprop-2-en-1-one
(6i)
1H NMR (400 MHz, CDCl3)
d
: 6.80 (d, JH-F = 36.0 Hz, 1H), 7.47–
F = 253.0 Hz), 186.1 (d, JC-F = 29.0 Hz). 19F NMR (376 MHz, CDCl3)
d
:
7.62 (m, 7H), 7.88 (d, J = 6.8 Hz, 2H). 13C NMR (100 MHz, CDCl3)
d:
ꢁ104.96, ꢁ120.23 (d, JH-F = 36.0 Hz). MS: m/z 259 [MH]+. HRMS
118.7 (d, JC-F = 5.6 Hz), 124.4 (d, JC-F = 4.9 Hz), 128.6, 129.4 (d, JC-
F = 4.0 Hz), 130.3 (d, JC-F = 4.4 Hz), 132.0 (d, JC-F = 8.2 Hz), 132.2,
133.1, 136.0, 154.7 (d, JC-F = 273.5 Hz), 187.6 (d, JC-F = 29.2 Hz). 19
calcd for C16H13F2O: 259.0934 [M+H], found: 259.0918.
F
4.3.4. (Z)-3-(4-chlorophenyl)-2-fluoro-1-(4-fluorophenyl)prop-2-
NMR (376 MHz, CDCl3)
d
: ꢁ118.01 (d, JH-F = 36.0 Hz). MS: m/z 305
en-1-one (6d)
[MH]+. HRMS calcd for C15H11BrFO: 304.9977 [M+H], found:
304.9989.
1H NMR (400 MHz, CDCl3)
d
: 6.85 (d, JH-F = 36.0 Hz, 1H), 7.15–
7.19 (m, 2H), 7.39 (d, J = 8.0 Hz, 2H), 7.62 (d, J = 8.0 Hz, 2H), 7.94–
7.97 (m, 2H). 13C NMR (100 MHz, CDCl3)
: 115.8 (d, JC-F = 22.0 Hz),
d
4.3.10. (Z)-2-fluoro-3-(4-methoxyphenyl)-1-phenylprop-2-en-1-one
118.1 (d, JC-F = 6.0 Hz), 129.2, 129.8 (d, JC-F = 4.0 Hz), 131.7, 131.8,
132.2 (dd, J1C-F = 9.5 Hz, J2C-F = 5.5 Hz), 136.0 (d, JC-F = 4.0 Hz), 154.7
(d, JC-F = 273.0 Hz), 165.7 (d, JC-F = 254.0 Hz), 185.7 (d, JC-
(6j)
1H NMR (400 MHz, CDCl3)
d
: 3.84 (s, 3H), 6.82 (d, JH-F = 36.8 Hz,
1H), 6.93 (d, J = 8.8 Hz, 2H), 7.48 (t, J = 7.8 Hz, 2H), 7.57–7.59 (m,